Codexis Website, Blog & Press Pages

Codexis Website, Blog & Press Pages - aVenture

Codexis - Library

codexis.comCrawled Oct 16, 2026

Careers & Hiring

2 pages

Careers/careers
Codexis offers career opportunities in science and other areas of expertise.
Work With Us/about-us/work-with-us
Codexis provides engineered enzymatic biocatalysis to optimize manufacturing, including solutions that support efficient RNA manufacturing.

Team

1 page

Leadership Team/about-us/leadership-team
The page introduces Codexis' leadership team, board, and CEO, who drive RNA and enzyme innovation.

About

4 pages

About us/about-us
Codexis specializes in pharmaceutical manufacturing for siRNA, pharma biocatalysis, and other enzyme services.
Culture and People/about-us/culture-and-people
The page describes Codexis' culture and the people who drive it to challenge what is possible.
Facilities/about-us/facilities
Explore Codexis' RNA manufacturing & enzyme engineering facility locations as well as contact information.
History/about-us/history
Codexis provides enzymatic solutions and siRNA manufacturing solutions.

Contact

1 page

Homepage

1 page

Homepage/
Codexis: RNA manufacturing and custom enzyme engineering for pharmaceuticals and siRNA therapeutics.

Privacy

1 page

Privacy Policy/privacy-policy
The website address is https://localhost/codexis. When visitors leave comments, the site collects form data, IP addresses, and browser user-agent strings for spam detection, and creates an anonymized string from email addresses.

Coverage

5 items

Codexis announces pricing of public offering of common stockir.codexis.com/news-events/press-releases/detail/449/codexis-announces-pricing-of-public-offering-of-common-stock
Codexis prices an underwritten public offering of 16,666,667 shares of common stock at $1.50 per share. The company expects the offering to generate about $23.1 million in net proceeds.
Jul 2026 · GlobeNewswireNews article
Codexis reports first quarter 2026 financial resultsir.codexis.com/news-events/press-releases/detail/446/codexis-reports-first-quarter-2026-financial-results
Codexis reports first-quarter 2026 financial results, including $15.2 million in revenue and $65.1 million in cash. The company reiterates full-year 2026 revenue guidance of $72 million to $76 million.
May 2026 · GlobeNewswireNews article
Codexis signs agreement to manufacture 50 g siRNA using ECO Synthesis platformir.codexis.com/news-events/press-releases/detail/442/codexis-signs-agreement-to-manufacture-50-g-sirna-using-its-eco-synthesis-manufacturing-platform
Codexis agrees to manufacture 50 grams of siRNA for a pharmaceutical partner’s preclinical cardiovascular program using its enzymatic ECO Synthesis platform. The pharmaceutical partner is not named in the provided text.
Mar 2026 · Codexis IR / PR NewswireNews article
Codexis expands ECO Synthesis reach with Axolabs evaluation agreementir.codexis.com/news-events/press-releases/detail/438/codexis-expands-reach-of-the-eco-synthesis-manufacturing-platform-through-a-signed-evaluation-agreement-with-axolabs-for-oligonucleotide-therapeutics
Codexis and Axolabs sign an evaluation agreement giving Axolabs access to the ECO Synthesis platform. The agreement supports evaluation of the platform for manufacturing scale-up of oligonucleotide therapeutics.
Jan 2026 · Codexis IR / PR NewswireNews article